Gd(DO3A-N-alpha-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents.
about
Basic MR relaxation mechanisms and contrast agent designAmide conjugates of the DO3A-N-(α-amino)propionate ligand: leads for stable, high relaxivity contrast agents for MRI?Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.Ln[DO3A-N-α-(pyrenebutanamido)propionate] complexes: optimized relaxivity and NIR optical properties.Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agentsA bis(pyridine N-oxide) analogue of DOTA: relaxometric properties of the Gd(III) complex and efficient sensitization of visible and NIR-emitting lanthanide(III) cations including Pr(III) and Ho(III).Gold nanoparticles functionalised with fast water exchanging Gd3+ chelates: linker effects on the relaxivity.Unexpected Changes in the Population of Coordination Isomers for the Lanthanide Ion Complexes of DOTMA-Tetraglycinate.Gold nanoparticles functionalised with stable, fast water exchanging Gd3+ chelates as high relaxivity contrast agents for MRI.Reporter protein-targeted probes for magnetic resonance imaging.The synthesis and application of polyamino polycarboxylic bifunctional chelating agents.A novel zinc bis(thiosemicarbazone) complex for live cell imaging.Synthesis and Characterization of Ligands and their Gadolinium(III) ComplexesStructure, Dynamics, and Computational Studies of Lanthanide-Based Contrast AgentsA concise synthesis procedure to furnish multi-gram amounts of hexadentate, bivalent DO2A-based chelatorsNew tris-3,4-HOPO lanthanide complexes as potential imaging probes: complex stability and magnetic properties
P2860
Q27692546-0ED9A028-37C4-4B84-80AC-BD4C01BE368CQ30575277-87E3D6BF-949A-4D8A-8611-FADDF32F9B21Q30577667-191685BF-082C-4BA3-8FF9-57BC574A1858Q30716845-1FBE01BB-9B3C-4733-95CB-0A78FAC06E03Q30830645-06B000F3-778E-4B5C-8214-977BC80203C7Q30853705-96042024-7093-4FB7-ADF0-D8BBF0EFF371Q30885568-5D4D72C1-357C-4118-9536-8BBD22290A6EQ31127191-29B87796-F49F-4C9D-8F61-A8E1229A4D9BQ34216365-02F91F6F-444B-40D3-BB56-B78E9AC0ECCDQ35468836-BBDFFF36-CEC1-4E08-97FB-A869007A082EQ37850696-2BFC278D-F571-46AC-856B-99EC87B12C0BQ44387606-12A78885-E6EB-4EFB-BEF5-42F5020F6A8CQ57340454-A1B162C5-EED0-4C6C-990E-D9FB0F9274D9Q57391311-A782F129-5AC5-4F1F-B84E-A9A4709076B7Q57391325-7A127949-FFA3-48B2-AEC0-FF5863396AA9Q58374529-4A25F574-832C-4585-BD94-056518E09642
P2860
Gd(DO3A-N-alpha-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Gd(DO3A-N-alpha-aminopropionat ...... targeted MRI contrast agents.
@ast
Gd(DO3A-N-alpha-aminopropionat ...... targeted MRI contrast agents.
@en
Gd(DO3A-N-alpha-aminopropionat ...... targeted MRI contrast agents.
@nl
type
label
Gd(DO3A-N-alpha-aminopropionat ...... targeted MRI contrast agents.
@ast
Gd(DO3A-N-alpha-aminopropionat ...... targeted MRI contrast agents.
@en
Gd(DO3A-N-alpha-aminopropionat ...... targeted MRI contrast agents.
@nl
prefLabel
Gd(DO3A-N-alpha-aminopropionat ...... targeted MRI contrast agents.
@ast
Gd(DO3A-N-alpha-aminopropionat ...... targeted MRI contrast agents.
@en
Gd(DO3A-N-alpha-aminopropionat ...... targeted MRI contrast agents.
@nl
P50
P356
P1476
Gd(DO3A-N-alpha-aminopropionat ...... targeted MRI contrast agents.
@en
P2093
Carlos F G C Geraldes
Miguel F Ferreira
P304
P356
10.1039/B912201J
P407
P577
2009-09-09T00:00:00Z